Additionally, a TMA (n = 52; WHO I‐III lower grade glioma, 26; WHO IV higher grade glioma, 26; see Supporting Information Figure S1A) revealed that NKCC1 is expressed in glioma tissues at a higher level in higher grade compared with lower grade gliomas (Figure 1e). The gene discussed is SLC12A2; the disease is glioma.